產品與服務醫療健康

賽雷納(中國)醫療科技有限公司

來源

賽雷納(中國)醫療科技有限公司,成立於 2013 年,主要產品為無創產前檢測及液體活檢相關醫療器械,其產品具有顛覆性的低成本和高精度優勢,在防控新生兒先天疾病和腫瘤篩查等方麵具有重要的臨床意義。2018 年,該公司獲得金域醫學(股票代碼: 603882 )和深圳前海邦勤投資有限公司(崗宏集團成員企業)聯合戰略投資。

Celula (China) Medical Science and Technology Company Limited, founded in 2013, mainly produces medical devices for noninvasive prenatal testing (NIPT) and liquid biopsy. With high precision and low cost, its medical devices are significant in preventing neonatal congenital diseases and screening tumor clinically.  In 2018, Celula has obtained joint strategic investment by Kingmed Diagnostics (stock code: 603882) and Shenzhen Qianhai Bangqin Investment Company Limited (a member of Ganghong Group). 


賽雷 (1).jpg